Targeted radiation shows promise in early breast cancer

Targeted radiation shows promise in early breast cancer

(HealthDay)—For women with early-stage breast cancer, targeted doses of radiation therapy may be as effective as standard radiation treatment of the entire breast, according to research presented at the European Breast Cancer Conference, held from March 9 to 11 in Amsterdam.

The researchers behind the new study randomly assigned 2,018 women with in the United Kingdom to undergo one of three approaches after having small cancerous tumors surgically removed. Two of the approaches focused the radiation around the tumor, exposing the rest of the breast to little or no radiation.

The researchers found that three weeks of partial breast radiation therapy produced fewer side effects but seemed just as effective as whole breast radiation over five years. Besides very low rates of relapse among all three groups, the rate of side effects from the target therapy was minimal.

The research only tracked women for five years, so it isn't definitive. Still, "this contributes to a growing body of evidence that a large proportion of women over 50 years old with small breast cancers can avoid whole breast radiotherapy," study coauthor John Yarnold, M.B.B.S., a professor of clinical oncology with the Institute of Cancer Research in London, told HealthDay.

More information: Press Release
More Information

Copyright © 2016 HealthDay. All rights reserved.

Citation: Targeted radiation shows promise in early breast cancer (2016, March 10) retrieved 28 May 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

ASTRO: Shorter radiation OK for early breast cancers


Feedback to editors